Proellex pharmacokinetic bridging study II

Trial Profile

Proellex pharmacokinetic bridging study II

Phase of Trial: Phase I

Latest Information Update: 20 Jun 2008

At a glance

  • Drugs Telapristone (Primary)
  • Indications Endometriosis; Uterine leiomyoma
  • Focus Pharmacokinetics
  • Sponsors Repros Therapeutics
  • Most Recent Events

    • 28 Mar 2008 The expected completion date for this trial is now 1 Apr 2008, as reported by
    • 28 Mar 2008 Status change from recruiting to in progress, as reported by
    • 26 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top